Gene · 9563
Papers3,177
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,177
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Ene Reductase, KlebER1, for the Production of Dihydrocarvone: Identification, Characterization, Engineering, and Application. | J Agric Food Chem | 2026 | 42043386 | PubTator, text mining | PubMed |
| Multi-walled carbon nanotube buckypaper with covalently bound NAD+ and immobilized glucose dehydrogenase for reagentless glucose biosensing. | Talanta | 2026 | 42035674 | PubTator, text mining | PubMed |
| Enhancing acidic catalytic performance of dual-enzyme system through chitosan-calcium pyrophosphate hybrid nanoflowers for efficient synthesis of chiral alcohols. | Enzyme Microb Technol | 2026 | 42033909 | PubTator, text mining | PubMed |
| From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer. | Eur J Cancer | 2026 | 41950572 | PubTator, text mining | PubMed |
| Asymmetric synthesis of propargylic alcohols using bifunctional glucose dehydrogenases. | Chem Commun (Camb) | 2026 | 41947742 | PubTator, text mining | PubMed |
| Glucose-6-phosphate dehydrogenase facilitates the synthesis of yellow Monascus pigment by providing energy. | Int J Biol Macromol | 2026 | 41934780 | PubTator, text mining | PubMed |
| PSAT1 Promotes NSCLC Progression via the De Novo Serine Synthesis Pathway and Represents a Therapeutic Vulnerability. | Cancer Med | 2026 | 41925099 | PubTator, text mining | PubMed |
| Integrative Multi-Analysis Identifies METTL3-Regulated FGF19 and H6PD as Candidate Targets in Diabetic Cognitive Impairment. | Biomolecules | 2026 | 41897403 | PubTator, text mining | PubMed |
| LDHA protects vascular endothelial cells from oxidative stress‑induced mitochondrial damage via HIF‑1α activation and glycolytic reprogramming. | Mol Med Rep | 2026 | 41891951 | PubTator, text mining | PubMed |
| Optimization of a cofactor regeneration system for sustainable xylitol production by xylose reductase from Debaryomyces nepalensis NCYC 3413. | Enzyme Microb Technol | 2026 | 41881880 | PubTator, text mining | PubMed |
| Co-Confinement of Enzymes and Cofactors Within Pickering Droplet Derived Microreactors for Continuous Flow Catalysis. | Angew Chem Int Ed Engl | 2026 | 41873022 | PubTator, text mining | PubMed |
| Activated astrocytes increase dehydroascorbic acid uptake, changing intracellular metabolism and vitamin C recycling and emulating neuropathological conditions. | Redox Biol | 2026 | 41830672 | PubTator, text mining | PubMed |
| Systematic and precise interventions for KRAS-mutant cancers. | Exp Hematol Oncol | 2026 | 41827015 | PubTator, text mining | PubMed |
| Screening of Heat-Resistant Morchella Strains and Elucidation of Their Heat-Tolerance Mechanisms. | Biology (Basel) | 2026 | 41823814 | PubTator, text mining | PubMed |
| Heterologous expression of 20α-hydroxysteroid dehydrogenase in Escherichia coli for the production of 20α-hydroxyprogesterone. | J Steroid Biochem Mol Biol | 2026 | 41794296 | PubTator, text mining | PubMed |
| 44-year journey (1980-2024): scientometric insights into Sigesbeckiae herba and update on its medicinal properties and phytochemicals profile. | Chin Med | 2026 | 41781974 | PubTator, text mining | PubMed |
| The spleen-brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation. | Alzheimers Dement | 2026 | 41778859 | PubTator, text mining | PubMed |
| l-Erythrulose Synthesis From Glycerol by a Multienzymatic Cascade Reaction. | ChemSusChem | 2026 | 41773477 | PubTator, text mining | PubMed |
| Performance evaluation of an automated method for accurate identification of glucose-6-phosphate dehydrogenase deficiency on the BS-2800M analyzer. | Malar J | 2026 | 41772588 | PubTator, text mining | PubMed |
| Reprogramming Imine Reductases for Enantioselective Reduction of Electron-Rich Enamides. | JACS Au | 2026 | 41755876 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9563/papers?page=2